1. Home
  2. ELTX vs ITRG Comparison

ELTX vs ITRG Comparison

Compare ELTX & ITRG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ELTX
  • ITRG
  • Stock Information
  • Founded
  • ELTX 2011
  • ITRG 1997
  • Country
  • ELTX United States
  • ITRG Canada
  • Employees
  • ELTX N/A
  • ITRG N/A
  • Industry
  • ELTX Biotechnology: Pharmaceutical Preparations
  • ITRG Precious Metals
  • Sector
  • ELTX Health Care
  • ITRG Basic Materials
  • Exchange
  • ELTX Nasdaq
  • ITRG Nasdaq
  • Market Cap
  • ELTX 49.7M
  • ITRG 84.2M
  • IPO Year
  • ELTX 2021
  • ITRG N/A
  • Fundamental
  • Price
  • ELTX $4.16
  • ITRG $1.20
  • Analyst Decision
  • ELTX Buy
  • ITRG Strong Buy
  • Analyst Count
  • ELTX 2
  • ITRG 1
  • Target Price
  • ELTX $10.00
  • ITRG $3.75
  • AVG Volume (30 Days)
  • ELTX 16.1K
  • ITRG 259.4K
  • Earning Date
  • ELTX 11-07-2024
  • ITRG 11-12-2024
  • Dividend Yield
  • ELTX N/A
  • ITRG N/A
  • EPS Growth
  • ELTX N/A
  • ITRG N/A
  • EPS
  • ELTX N/A
  • ITRG N/A
  • Revenue
  • ELTX N/A
  • ITRG N/A
  • Revenue This Year
  • ELTX N/A
  • ITRG N/A
  • Revenue Next Year
  • ELTX N/A
  • ITRG $360.53
  • P/E Ratio
  • ELTX N/A
  • ITRG N/A
  • Revenue Growth
  • ELTX N/A
  • ITRG N/A
  • 52 Week Low
  • ELTX $2.96
  • ITRG $0.64
  • 52 Week High
  • ELTX $11.45
  • ITRG $1.28
  • Technical
  • Relative Strength Index (RSI)
  • ELTX 40.82
  • ITRG 66.49
  • Support Level
  • ELTX $4.05
  • ITRG $0.95
  • Resistance Level
  • ELTX $4.89
  • ITRG $1.28
  • Average True Range (ATR)
  • ELTX 0.28
  • ITRG 0.07
  • MACD
  • ELTX -0.06
  • ITRG 0.01
  • Stochastic Oscillator
  • ELTX 27.37
  • ITRG 77.27

About ELTX Elicio Therapeutics Inc.

Elicio Therapeutics Inc is a clinical-stage biotechnology company pioneering the development of cancer immunotherapies for patients with limited treatment options and poor outcomes. Its proprietary Amphiphile, or AMP, platform delivers investigational immunotherapeutics directly to the brain center of the immune system the lymph nodes. Its focus is the development of cancer immunotherapies against biologically validated but hard-to-drug targets that can be activated through lymph node trafficking. Elicio is engineering lymph node-targeted AMPlifiers, immunomodulators, adjuvants, and vaccines for an array of aggressive cancers. It has developed its cancer vaccine product candidates to target biologically validated tumor mutation drivers using known neoantigens.

About ITRG Integra Resources Corp.

Integra Resources Corp is a precious metals exploration and development company in the Great Basin of the Western USA. Integra is currently focused on advancing its two flagship oxide heap leach projects: the past-producing DeLamar Project located in southwestern Idaho and the Nevada North Project, comprised of the Wildcat and Mountain View deposits, located in northwestern Nevada. The company also holds a portfolio of highly prospective early-stage exploration projects in Idaho, Nevada, and Arizona.

Share on Social Networks: